Skip to main content
. 2023 Jan 12;11(2):240. doi: 10.3390/healthcare11020240

Table 2.

Drug doses and costs for cost-effectiveness analyses.

Average Dose (Original) (mg) Average Dose (Matched) (mg) Cost per Dose
(USD·mg−1)
Neuromuscular blocking and
reversal agents
N group S group N group S group
Rocuronium 59.4 70.1 62.6 62.9 0.28
Neostigmine 2.6 0 2.6 0 1.40
Glycopyrrolate 0.6 0.1 0.6 0.1 3.50
Sugammadex 0 144.3 0 143.9 1.17

N group = neostigmine group; S group = sugammadex group. USD = United States dollar.